“Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2008.
“Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms”, presented at the 2008, Bangkok, Thailand, 2008.
, “One-Unit Versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers”, N Engl J Med, vol. 371, pp. 1685-1694, 2014.
, “Time Sensitive Parameters of Immune Reconstitution Measured Between Day 100 and 1 Year Predict Survival After Unrelated Cord Blood Transplant (UCBT): The Dynamic Impact of Dendritic Cells, Tregs, and Thymic Recovery.”, in European Society of Hematology World Cord Blood Congress, Marseille, 2010.
, “Analysis of the NAPRTCS Pediatric Dialysis Registry,”, Clinical Dialysis, vol. 43, pp. 938-43, 1995.
, “Reticular Drusen as a Baseline Risk Factor for Progression to Advanced AMD in AREDS”, presented at the 01/05/2005, Fort Lauderdale, FL, 2005.
, “Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood and Marrow Transplant Clinical Trials Network Study”, Blood, vol. 119, pp. 3854-3860, 2012.
, “Lessons from IAVI-006, a Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the PTHR.HIVA DNA and MVA.HIVA Vaccines in a Prime-Boost Strategy to Induce HIV-1 Specific T-Cell Responses in Healthy Volunteers”, Vaccine, vol. 26, pp. 6671-6677, 2008.
, “Clinical trials referral resource. Clinical trials in elderly patients.”, Oncology, vol. 11, pp. 838-44, 1997.
, “Clinical trials referral resource. Clinical trials with PSC-833”, Oncology, vol. 11, pp. 490-3, 1997.
, “Retrospective Studies: A Fresh Look.”, Am J Speech Lang Pathol, vol. 25, no. 2, pp. 157-63, 2016.
, “Evaluation of the Mercy TAPE: Performance Against the Standard for Pediatric Weight”, Ann Emerg Med, vol. 62, pp. 332-339.e6, 2013.
, “Validation and human factor analysis study of an infant weight estimation device.”, BMC Pediatr, vol. 20, no. 1, p. 30, 2020.
, “Evaluation of the Mercy TAPE: performance against the standard for pediatric weight estimation.”, Ann Emerg Med, vol. 62, no. 4, pp. 332-339.e6, 2013.
, “Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study”, in American Society of Hematology (ASH), 2020.
, “Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study”, Blood Adv, vol. 7, no. 14, pp. 3506-3515, 2023.
, “Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study”, in 62nd ASH Annual Meeting and Exposition, 2020.
, “Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer.”, J Natl Cancer Inst, vol. 87, no. 24, pp. 1837-45, 1995.
, “Clinical trials referral resource. Current cooperative group phase III clinical trials in early-stage breast cancer.”, Oncology (Williston Park), vol. 15, no. 2, pp. 176-7, 181-2, 185, 2001.
, “Paclitaxel Activity in Heavily Pretreated Breast Cancer: A National Cancer Institute Treatment Referral Center Trial”, J Clin Oncol, vol. 13, pp. 2056-2065, 1995.
, “Clinical trials referral resource. Current phase III, NCI-supported, Cooperative Group Clinical Trials in breast cancer.”, Oncology (Williston Park), vol. 18, no. 4, pp. 463-4, 467-8, 470, 2004.
, “Meeting Highlights: A Reappraisal of Research Results For the Local Treatment of Early Stage Breast Cancer”, J Natl Cancer Inst, vol. 87, pp. 1837-1845, 1995.
, “Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial.”, J Clin Oncol, vol. 13, no. 8, pp. 2056-65, 1995.
, “Current Cooperative Group phase III clinical trials in early stage breast cancer”, Oncology, vol. 15, pp. 52-56, 2001.
, ,